|January 30, 2014|
|07:39 EDT||CVS, CAH||Cardinal Health sees CVS Caremark venture operational as soon as July 1|
In December 2013, Cardinal Health (CAH) and CVS Caremark (CVS) announced the signing of an agreement to form the largest generic sourcing entity in the U.S. Both companies are contributing their sourcing and supply chain expertise to the 50/50 joint venture and are committing to source generic drugs through it. The U.S.-based joint venture is expected to be operational as soon as July 1 and will have an initial term of 10 years, Cardinal said.
News For CAH;CVS From The Last 14 Days
|October 5, 2015|
|10:02 EDT||CVS||Bofa/Merrill healthcare analysts hold an analyst/industry conference call|
Subscribe for More Information
|October 4, 2015|
|19:07 EDT||CAH||Cardinal Health sees Cordis acquisition adding more than 20c to FY17 EPS|
Subscribe for More Information
|October 2, 2015|
|08:21 EDT||CVS||Amazon to be number two player in U.S. consumables by 2018, says Cowen|
John Blackledge and the research team at Cowen project that Amazon.com (AMZN) will grow to be the number two player in the $425B market for U.S. consumables - which they define as personal care, household, pet and baby products - by 2018. The firm expects Amazon to use its multi-platform approach, centered around Prime, to help the e-commerce giant gain share in consumables at the expense of Wal-Mart (WMT), Target (TGT), Walgreens (WBA) and CVS Health (CVS). Cowen has Outperform ratings on Amazon and Target and a Market Perform rating on shares of Wal-Mart.
|October 1, 2015|
|10:50 EDT||CAH, CVS||Leerink healthcare services analyst holds analyst/industry conference call|
Analyst Larsen, along with Dan Steiber of D2 Pharma Consulting and James Kenney, Jr., of Harvard Pilgrim Health Care, discuss Hillary Care's potential impact to the Prescription Drug Supply Chain, the impact of the Medicaid rebate program and the uptake of bio-similars and generic launches in 2015 on an Analyst/Industry conference call to be held on October 2 at 12 pm.
|September 30, 2015|
|10:47 EDT||CAH, CVS||Leerink analyst/industry conference call date/time changed from October 8 10 am|
Healthcare Distribution & Technology Larsen, along with Diplomat Pharmacy Chairman & CEO Hagerman and CFO & Secretary/Treasurer Whelan, provide industry insights including the potential impact of Hillary Care, the influence CMS may have on overall drug pricing and recent stock volatility on an Analyst/Industry conference call now being held at a new date and time of September 30 at 5 pm.
|09:05 EDT||CVS||CVS Health announces partnership with MassChallenge and Rock Health|
CVS Health announced that it was partnering with top startup accelerator MassChallenge and digital health venture fund Rock Health to drive faster innovation and expand areas of focus for connected health solutions.
|September 22, 2015|
|10:45 EDT||CVS||Reimbursement pressure on drug stores should moderate, says Cleveland Research|
Cleveland Research analysts Rob Eich and Rob Stuyck said the firm's work indicates that stepdown reimbursement rates will be more manageable for drug store operators and that generic inflation will be less of a headwind for the group in FY16. However, Direct and Indirect Remuneration clauses will still be a source of margin pressure, the firm said, noting that several payers will be introducing a DIR next year. Cleveland Research has Neutral ratings on CVS (CVS), Walgreens (WBA), Rite Aid (RAD) and Wal-Mart (WMT).
|07:38 EDT||CAH||UBS to hold a conference|
Healthcare Supply Channel & Tech Conference is being held in Boston on September 22.